Products for Research Use Only
RegisterLogin

Moexipril (hydrochloride)

CAT: 0804-HY-B0378A-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B0378A-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Moexipril hydrochloride (RS-10085) is an orally active inhibitor of angiotensin-converting enzyme (ACE), and becomes effective by being hydrolyzed to moexiprila (hydrochloride) . Moexipril hydrochloride exhibits antihypertensive and neuroprotective effects[1]-[4].
CAS Number
82586-52-5
Product Name Alternative
RS-10085
UNSPSC
12352005
Hazard Statement
H400
Target
Angiotensin-converting Enzyme (ACE) ; Apoptosis
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/Moexipril-hydrochloride.html
Concentration
10mM
Purity
98.42
Solubility
DMSO : 250 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)
Smiles
O=C([C@H]1N(C([C@@H](N[C@H](C(OCC)=O)CCC2=CC=CC=C2)C)=O)CC3=C(C=C(OC)C(OC)=C3)C1)O.Cl
Molecular Formula
C27H35ClN2O7
Molecular Weight
535.03
Precautions
H400
References & Citations
[1]Chrysant, S.G. and G.S. Chrysant, Pharmacological and clinical profile of moexipril: a concise review. J Clin Pharmacol, 2004. 44 (8) : p. 827-36.|[2]Edling, O., et al., Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril. J Pharmacol Exp Ther, 1995. 275 (2) : p. 854-63.|[3]Friehe H, et al. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride. Arzneimittelforschung. 1997 Feb. 47 (2) :132-44.|[4]Ravati A, et al. Enalapril and moexipril protect from free radical-induced neuronal damage in vitro and reduce ischemic brain injury in mice and rats. Eur J Pharmacol. 1999 May 28;373 (1) :21-33.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched

Related Products

CatalogName
HY-B0378AS-01Moexipril-d5 (hydrochloride)
HY-117281Moexipril
HY-117281S1Moexipril-d3
HY-117281S-01Moexipril-d5
HY-B0500BAlverine (hydrochloride)
HY-W714513VU0469650 (hydrochloride)
HY-W708286-01α-Pyrrolidinobutiothiophenone (hydrochloride)
HY-W492795Quifenadine (hydrochloride)
HY-W012179-01Phenylpiperazine (hydrochloride)
HY-Z6449-01Phenylephrone (hydrochloride)

Alternative Products

CatalogName
255888-01Moexipril hydrochloride
sc-487475Moexipril-d3 Hydrochloride
sc-487473Moexipril-d4 Hydrochloride
A11745-100Moexipril hydrochloride 100mg
A11745-10Moexipril hydrochloride 10mg
A11745-200Moexipril hydrochloride 200mg
A11745-50Moexipril hydrochloride 50mg
A11745-25Moexipril hydrochloride 25mg
MBS6070490-01Moexipril Cyclohexyl Analogue Hydrochloride
GEC84117-01Moexipril methyl ester analog hydrochloride

Popular Products